Medication Use
Trends in asthma medication use by patients in the TA-B-BAL and control group are illustrated in Figure 3 . Four patients from the TA-B-BAL group were able to discontinue all respiratory medications at the time of the second post-operative visit. The average inhaled corticosteroid (ICS) dose at initial assessment was higher in the TA-B-BAL group (250.0mg) compared to the controls (100.0mg). Following medical management, the average ICS dose in the TA-B-BAL group was 193.8mg. Post operatively, ICS dose in the TA-B-BAL group decreased to 150.0mg. At a time point matched with the TA-B-BAL group post-operative visit, the controls average ICS dose was 210.4mg following standard medical management of asthma (Figure 4 ).